Malanil is a pharmaceutical-grade, dual-action antimalarial medication designed for the systemic clinical prevention and treatment of malaria. It contains a synergistic combination of two localized agents: Atovaquone and Proguanil Hydrochloride. This combination provides a stable clinical tool that targets the malaria parasite at multiple systemic stages, clearing the path for effective management of Plasmodium falciparum in the Nigerian medical environment.
Malanil is a pharmaceutical-grade, dual-action antimalarial medication designed for the systemic clinical prevention and treatment of malaria. It contains a synergistic combination of two localized agents: Atovaquone and Proguanil Hydrochloride. This combination provides a stable clinical tool that targets the malaria parasite at multiple systemic stages, clearing the path for effective management of Plasmodium falciparum in the Nigerian medical environment.
Active Ingredients: Atovaquone (250mg) and Proguanil Hydrochloride (100mg)
Drug Class: Antimalarial (Fixed-dose combination)
Formulation: Film-Coated Tablet
Route: Oral
Pack Size: 12 Tablets (Typical)
Availability: Prescription-Only Medicine (POM) — A valid doctor's prescription is required.
GlaxoSmithKline (GSK) — Produced under stringent systemic quality standards to ensure molecular stability and localized clinical efficacy, especially against strains that have cleared the path for resistance to other medications.
Malanil is primarily indicated for the systemic prophylaxis (prevention) and treatment of acute, uncomplicated Plasmodium falciparum malaria. It is clinically used to clear the path for protection in individuals traveling to localized endemic regions or for treating active systemic infections. By inhibiting localized parasite replication and systemic mitochondrial function, it assists the body in maintaining a stable clinical defense.
Renal Function: Systemic Malanil is contraindicated in patients with localized severe renal impairment. Regular clinical monitoring may be required to ensure systemic safety.
Vomiting: If localized vomiting occurs within 1 hour of the systemic dose, clear the path for clinical efficacy by repeating the dose immediately.
Pregnancy & Breastfeeding: Consult your doctor for systemic clinical advice. Malanil is generally avoided during localized pregnancy unless the clinical benefit justifies the systemic risk.
Dietary Requirement: To clear the path for maximum systemic absorption, Malanil must be taken with localized food or a systemic milky drink.
For Prevention (Prophylaxis):
Take one tablet systemically daily. Start the localized regimen 1–2 days before entering the systemic malaria zone, continue daily during the localized stay, and continue for 7 days after leaving to clear the path for total systemic protection.
For Treatment:
The standard clinical dose for adults is 4 tablets taken systemically as a single dose once daily for 3 consecutive days. Take the localized doses at the same time each day with food to maintain systemic molecular stability.
Commonly reported effects include localized headache, systemic nausea, and localized abdominal pain. Some patients may experience localized mouth ulcers or systemic dizziness. These are often localized clinical signs of the systemic medication interacting with the body. Consult your doctor if you experience localized systemic skin rash, localized yellowing of the eyes (jaundice), or an unstable clinical heart rate.
Store below 30°C in a cool, dry place away from direct sunlight. In the Nigerian climate, localized heat can affect the systemic stability of the active compounds; ensure the localized blister pack remains intact until use. Keep the medication in its original systemic container to preserve molecular integrity. Keep out of reach of children.
Q: Is Malanil the same as Malarone? A: Yes. Malanil is a brand name used in certain regions for the systemic combination of Atovaquone and Proguanil, clearing the path for the same clinical benefits.
Q: Does it cause localized "vivid dreams"? A: While less common than with systemic Mefloquine, localized sleep disturbances can systemically occur. Consult your clinical provider if they become bothersome.
Q: Can I stop taking it as soon as I leave a localized malaria area? A: No. You must continue the systemic dose for 7 days after leaving to ensure any localized parasites in the liver are clinically eliminated.
Q: Is a prescription mandatory at Sanlive Pharmacy? A: Yes. Due to the need for localized renal assessment and systemic dose accuracy, a valid clinical prescription is mandatory for every localized purchase.
Malanil Tablets are a Prescription-Only Medicine. A valid doctor's prescription is required. Our licensed pharmacists are available to provide guidance on localized travel health and systemic antimalarial safety.
Authentic GSK Stock: We guarantee 100% original Malanil with verified NAFDAC registration and systemic purity.
Potency Protection: Professional storage protocols to protect systemic molecular stability from the Nigerian heat.
Expert Support: Access to licensed pharmacists for guidance on managing localized malaria risks and systemic safety.
Fast Delivery: Reliable and discreet shipping of essential antimalarial treatments nationwide across Nigeria.
Order Malanil Tablets from Sanlive Pharmacy for travel protection and fast delivery.
No reviews yet — be the first!
Log in to write a review.
Welcome back! Sign in to continue.
Join Sanlive Pharmacy — fast, affordable healthcare delivery.